occurs in has participant quality has disease treated with drug INTERFERON ALFA-2A MEGESTROL TOPOTECAN ATORVASTATIN ROPINIROLE CLOPIDOGREL FLUOROURACIL CYTARABINE LEUPROLIDE ACETATE CARBOPLATIN CAPSAICIN SELEGILINE TICLOPIDINE LOSARTAN POTASSIUM ANASTROZOLE BICALUTAMIDE ZOLMITRIPTAN CAPECITABINE EFAVIRENZ TRASTUZUMAB RABEPRAZOLE TENOFOVIR TRIPTORELIN TESAMORELIN female breast cancer pain disorder prostate cancer prostate carcinoma hypertension lymphocytic choriomeningitis leiomyoma Parkinson's disease breast cancer ovarian cancer endometriosis cervical cancer human immunodeficiency virus infectious disease migraine cerebrovascular disease lipodystrophy gastroesophageal reflux disease chronic myeloid leukemia anorexia nervosa intermediate coronary syndrome actinic keratosis colorectal cancer Elderly Child Adult pain AE 10033371 YH, MW CTCAE: E11167 NCIt: C3303 a sensory capability AE that has an outcome of pain in a patient SIDER: C0030193 HPO: HP_0010833 sensory capability AE AE severity G1 AE severity G2 AE severity G3